IDH mutations have previously been associated with global DNA hypermethylation in AML as a result of the generation of the oncometabolite 2-HG, which inhibits TET-mediated DNA demethylation [5, 9]. This evidence concerns the gene IDH1 and acute myeloid leukemia.